Patents Assigned to Calosyn Pharma, Inc.
  • Publication number: 20140256746
    Abstract: A method and composition for treating osteoarthritis with ion-channel regulators is disclosed. The ion-channel regulators are used alone or in combination with other osteoarthritis treatment agents, including but not limited to injectable agents such as viscosupplements and steroids. A composition comprising one or more ion-channel regulator(s) and one or more osteoarthritis treatment agent(s) is also disclosed.
    Type: Application
    Filed: September 10, 2013
    Publication date: September 11, 2014
    Applicant: CALOSYN PHARMA, INC.
    Inventor: David D. Waddell
  • Patent number: 8557865
    Abstract: A method and composition for treating osteoarthritis with ion-channel regulators is disclosed. The ion-channel regulators are used alone or in combination with other osteoarthritis treatment agents, including but not limited to injectable agents such as viscosupplements and steroids. A composition comprising one or more ion-channel regulator(s) and one or more osteoarthritis treatment agent(s) is also disclosed.
    Type: Grant
    Filed: June 21, 2010
    Date of Patent: October 15, 2013
    Assignee: Calosyn Pharma, Inc.
    Inventor: David D. Waddell
  • Patent number: 8329746
    Abstract: A method and composition for treating osteoarthritis with ion-channel regulators is disclosed. The ion-channel regulators are used alone or in combination with other osteoarthritis treatment agents, including but not limited to injectable agents such as viscosupplements and steroids. A composition comprising one or more ion-channel regulator(s) and one or more osteoarthritis treatment agent(s) is also disclosed.
    Type: Grant
    Filed: July 2, 2012
    Date of Patent: December 11, 2012
    Assignee: CaloSyn Pharma, Inc.
    Inventor: David D. Waddell
  • Patent number: 7767710
    Abstract: A method and composition for treating osteoarthritis with ion-channel regulators is disclosed. The ion-channel regulators are used alone or in combination with other osteoarthritis treatment agents, including but not limited to injectable agents such as viscosupplements and steroids. A composition comprising one or more ion-channel regulator(s) and one or more osteoarthritis treatment agent(s) is also disclosed.
    Type: Grant
    Filed: May 25, 2005
    Date of Patent: August 3, 2010
    Assignee: Calosyn Pharma, Inc.
    Inventor: David D. Waddell